1. Pfizer Terminates Domagrozumab trial for the treatment of Duchenne muscular dystrophy

Published: 30 Aug,2018 |Tags: Pfizer, Terminates, Domagrozumab, Treatment, DMD

2. MedImmune (AZ) reports results of TULIP 1 P-III for anifrolumab in systemic lupus erythematosus

Published: 31 Aug,2018 |Tags: TULIP 1 P-III, anifrolumab, SLE, results

3. FDA Reports Newly Added Guidelines for Drug and Device Makers

Published: 20-30 Aug,2018 |Tags: Guidelines, Oncology, Depression, Smoking, OA, Opioid use

4. Vertex and Genomics plc forms a three-year collaboration extendable up to five years for Precision Medicines

Published: 30 Aug,2018 |Tags: Vertex, Genomics, Collaboration, Human Genetics, Data Science, Precision Medicines

5. BMS's Sprycel (dasatinib) sBLA Receives Positive Response from the US FDA

Published: 30 Aug,2018 |Tags: Bristol-Myers, application, Sprycel, Philadelphia Chromosome, ALL

6. AstraZeneca's Bydureon BCise Receives EU approval Once-Weekly Prefilled Syringe for Type2 Diabetes

Published: 30 Aug,2018 |Tags: AstraZeneca, Bydureon BCise, EU, Type-2 diabetes

7. Roche's Hemlibra P-III Positive results for Haemophilia A without factor VIII being published in NEJM

Published: 30 Aug,2018 |Tags: Positive, Results, Roche, Hemlibra, Haemophilia A, Factor VIII

9.Amgen's BLINCYTO (blinatumomab, BiTE) Receives EU Expanded approval for pediatric 2L+ B-cell-ALL

Published: 29 Aug,2018 |Tags: EU, Approval, BLINCYTO, Philadelphia chromosome-ve, B-cell ALL

8. Xenon Pharmaceutical Reports Positive Results of XEN1101 P-1b TMS (transcranial magnetic stimulation) study

Published: 29 Aug,2018 |Tags: Xenon, Announces, Positive, XEN1101, P-ITMS study

10. Emergent BioSolutions to Acquires Adapt Pharma with Narcan (naloxone HCl) Nasal Spray

Published: 28 Aug,2018 |Tags: Emergent, Acquire, Adapt Pharma, Narcan nasal spray

11. Alcon Announces Global Removal of CyPass Micro-Stent for Surgical Glaucoma

Published: 29 Aug,2018 |Tags: Alcon, announces, global, removal, CyPass Micro-Stent

12. NICE, UK Rejects Gilead's Yescarta for Being Too Expensive

Published: 28 Aug,2018 |Tags: NICE, Rejects, Yescarta, Gilead, Expensive

13. Biogen and Eisai Reports Results of Long-Term Extension P-Ib study for aducanumab

Published: 28 Aug,2018 |Tags: Biogen, Eisai, Results, P-Ib study, aducanumab, Alzheimer Disease

14. Affimed Formed a Research Collaboration with Genentech for Novel NK Cells

Published: 27 Aug,2018|Tags: Affimed, Genentech, Collaboration, Novel NK cells, Multiple cancer

15. Pfizer Announces Tafamidis P-III Transthyretin Cardiomyopathy (ATTR-ACT) study results

Published: 27 Aug,2018|Tags: Pfizer, Announces, Tafamidis, P-III Transthyretin Cardiomyopathy (ATTR-ACT), Results

16. AbbVie Receives US FDA Approval for Imbruvica plus Rituximab for treatment of Waldenström's macroglobulinemia (WM)

Published: 27 Aug,2018 |Tags: AbbVie, Us FDA, approval, Imbruvica, Rituximab, WM

17. Kite's Yescarta Receives EU Marketing Approval

Published: 27 Aug,2018 |Tags: Yescarta, Receives, EU, Authorization, DLBCL, PMBCL

18. Abbott India Plans to Launch 100 products in next 5 years

Published: 27 Aug,2018 |Tags: Abbott India, Launch, 100 products, 5 years

19. Novartis's Kymriah Receives EU Approval

Published: 27 Aug,2018 |Tags: Novartis, Receives, EU, Approval, CAR-T therapy, Kymriah